Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.614 SEK | -4.06% | -7.25% | -50.08% |
Apr. 16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
Mar. 08 | Transcript : Nanexa AB - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.08% | 7.96M | |
-59.15% | 81.88M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa AB Provides Updates on its Patent Grant